Indianapolis, IN – CEDIA Expo 2005 – September 7, 2005 – PerkinElmer Optoelectronics, a global technology leader in digital imaging, specialty lighting and optical detection technologies, today announced that a new front projector design, which features the next-generation in Cermax Xenon technology, a high performance light engine for video projection in home theater applications, will be on display at CEDIA Expo 2005.
Using PerkinElmer’s Cermax Xenon light engine design, customers such as Sony (CEDIA Booth #150) are now able to meet high levels of brightness, color fidelity, image quality and lamp lifetime requirements, all needed to exceed consumer expectations in the home theater market. PerkinElmer’s new Cermax Xenon technology delivers improved high lumen output, superior lamp life, greater lamp-to-lamp predictability, better image clarity, a competitive market-based price point, reduced size, and super-quiet operation, offering customers a superior alternative to mercury-based products.
“We are confident that the use of our technology will bring our customers competitive differentiation in the marketplace. In addition, it will enable PerkinElmer to capitalize on the rapidly growing home theater projection market opportunity. We are extremely pleased that customers such as Sony are selecting Cermax Xenon technology for their high profile new product introductions,” said John Roush, President, PerkinElmer Optoelectronics.
PerkinElmer’s next generation Cermax Xenon technology offers higher efficacy, low noise operation, and excellent etendue, making it the perfect light engine for large screen viewing in the home venue. Furthermore, Cermax Xenon-based microdisplays are the only ones with true instant on/off capabilities. Additional advantages of PerkinElmer’s Cermax Xenon technology include its single lamp design and simple DC operation which reduces sequencing and flicker issues. Cermax Xenon lamps are based on inert, non-toxic xenon gas which offers an environmentally-safe alternative to mercury lamps.
PerkinElmer Optoelectronics is a global technology leader providing market-driven, integrated solutions for biomedical and industrial applications. Its technologies, services, and support fuel the medical, genomic and digital revolutions by enhancing its customers’ productivity, optimizing their performance, and accelerating their time-to-market. More information about PerkinElmer Optoelectronics recent announcements is available at http://optoelectronics.perkinelmer.com/.
Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments, including, without limitation, all projections of future financial results and plans concerning business development opportunities, are deemed to be forward-looking statements. Words such as “believes,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions are intended to identify forward-looking statements. There are a number of important risk factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including, without limitation, economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries, risks related to our failure to introduce new products in a timely manner, the impact of our debt on our cash flow and investment opportunities, our ability to comply with financial covenants contained in our credit agreements and debt instruments, cyclical downturns continuing to affect several of the industries into which we sell our products, our ability to adjust our operations to address unexpected changes, our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business, the loss of any of our licenses that may require us to stop selling products or lose competitive advantage, competition, regulatory compliance, regulatory changes, our failure to obtain and enforce intellectual property protection, our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets, as well as other factors which we describe under the caption “Forward-Looking Information and Factors Affecting Future Performance” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q, each on file with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Industrial Sciences markets to improve the quality of life. The Company reported revenues of $1.7 billion in 2004, has 10,000 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.Where to Buy